These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 27138828)

  • 1. Factors affecting severity of positive and negative symptoms of psychosis in a polysubstance using population with psychostimulant dependence.
    Willi TS; Honer WG; Thornton AE; Gicas K; Procyshyn RM; Vila-Rodriguez F; Panenka WJ; Aleksic A; Leonova O; Jones AA; MacEwan GW; Barr AM
    Psychiatry Res; 2016 Jun; 240():336-342. PubMed ID: 27138828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of psychotic symptoms in subjects with methamphetamine versus cocaine dependence.
    Alexander PD; Gicas KM; Willi TS; Kim CN; Boyeva V; Procyshyn RM; Smith GN; Thornton AE; Panenka WJ; Jones AA; Vila-Rodriguez F; Lang DJ; William MacEwan G; Honer WG; Barr AM
    Psychopharmacology (Berl); 2017 May; 234(9-10):1535-1547. PubMed ID: 28190084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is there a discrete negative symptom syndrome in people who use methamphetamine?
    Voce A; Burns R; Castle D; Calabria B; McKetin R
    Compr Psychiatry; 2019 Aug; 93():27-32. PubMed ID: 31301605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subcortical grey matter alterations in cocaine dependent individuals with substance-induced psychosis compared to non-psychotic cocaine users.
    Willi TS; Lang DJ; Honer WG; Smith GN; Thornton AE; Panenka WJ; Procyshyn RM; Vila-Rodriguez F; Su W; Vertinsky AT; Leonova O; Rauscher A; MacEwan GW; Barr AM
    Schizophr Res; 2016 Oct; 176(2-3):158-163. PubMed ID: 27499362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in the symptom profile of methamphetamine-related psychosis and primary psychotic disorders.
    McKetin R; Baker AL; Dawe S; Voce A; Lubman DI
    Psychiatry Res; 2017 May; 251():349-354. PubMed ID: 28282630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
    McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
    JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The profile of psychiatric symptoms exacerbated by methamphetamine use.
    McKetin R; Dawe S; Burns RA; Hides L; Kavanagh DJ; Teesson M; McD Young R; Voce A; Saunders JB
    Drug Alcohol Depend; 2016 Apr; 161():104-9. PubMed ID: 26874915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hostility among methamphetamine users experiencing psychotic symptoms.
    McKetin R; McLaren J; Lubman DI; Hides L
    Am J Addict; 2008; 17(3):235-40. PubMed ID: 18464001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The prevalence of psychotic symptoms among methamphetamine users.
    McKetin R; McLaren J; Lubman DI; Hides L
    Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between gender and psychotic symptoms in cocaine-dependent and methamphetamine-dependent participants.
    Mahoney JJ; Hawkins RY; De La Garza R; Kalechstein AD; Newton TF
    Gend Med; 2010 Oct; 7(5):414-21. PubMed ID: 21056868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary and substance-induced psychotic disorders in methamphetamine users.
    Hides L; Dawe S; McKetin R; Kavanagh DJ; Young RM; Teesson M; Saunders JB
    Psychiatry Res; 2015 Mar; 226(1):91-6. PubMed ID: 25677394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence and persistence of psychotic symptoms in cocaine- versus methamphetamine-dependent participants.
    Mahoney JJ; Kalechstein AD; De La Garza R; Newton TF
    Am J Addict; 2008; 17(2):83-98. PubMed ID: 18393050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychotic symptoms in methamphetamine psychotic in-patients.
    Srisurapanont M; Ali R; Marsden J; Sunga A; Wada K; Monteiro M
    Int J Neuropsychopharmacol; 2003 Dec; 6(4):347-52. PubMed ID: 14604449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
    Yang M; Yang C; Liu T; London ED
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparisons of methamphetamine psychotic and schizophrenic symptoms: a differential item functioning analysis.
    Srisurapanont M; Arunpongpaisal S; Wada K; Marsden J; Ali R; Kongsakon R
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):959-64. PubMed ID: 21277930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of ketamine use on psychotic disorders and symptoms in male, methamphetamine-dependent subjects.
    Dong H; Yang C; Shen Y; Liu L; Liu M; Hao W
    Am J Drug Alcohol Abuse; 2019; 45(3):276-284. PubMed ID: 30640573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A systematic review of risk factors for methamphetamine-associated psychosis.
    Arunogiri S; Foulds JA; McKetin R; Lubman DI
    Aust N Z J Psychiatry; 2018 Jun; 52(6):514-529. PubMed ID: 29338289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of methamphetamine psychosis: history of ADHD-relevant childhood behaviors and drug exposure.
    Salo R; Fassbender C; Iosif AM; Ursu S; Leamon MH; Carter C
    Psychiatry Res; 2013 Dec; 210(2):529-35. PubMed ID: 23896355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direction of the relationship between methamphetamine use and positive psychotic symptoms in regular methamphetamine users: evidence from a prospective cohort study.
    Hides L; Chan G; Dawe S; McKetin R; Kavanagh DJ; Young RM; Teesson M; Saunders JB
    Br J Psychiatry; 2021 Jul; 219(1):361-367. PubMed ID: 31950892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risks of psychosis in methamphetamine users: cross-sectional study in Thailand.
    Lamyai W; Pono K; Indrakamhaeng D; Saengsin A; Songhong N; Khuwuthyakorn P; Sribanditmongkol P; Junkuy A; Srisurapanont M
    BMJ Open; 2019 Oct; 9(10):e032711. PubMed ID: 31615802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.